Literature DB >> 19127223

Force frequency relationship of the human ventricle increases during early postnatal development.

Rob F Wiegerinck1, Anca Cojoc, Carlo M Zeidenweber, Guoliang Ding, Ming Shen, Ronald W Joyner, Janet D Fernandez, Kirk R Kanter, Paul M Kirshbom, Brian E Kogon, Mary B Wagner.   

Abstract

Understanding developmental changes in contractility is critical to improving therapies for young cardiac patients. Isometric developed force was measured in human ventricular muscle strips from two age groups: newborns (<2 wk) and infants (3-14 mo) undergoing repair for congenital heart defects. Muscle strips were paced at several cycle lengths (CLs) to determine the force frequency response (FFR). Changes in Na/Ca exchanger (NCX), sarcoplasmic reticulum Ca-ATPase (SERCA), and phospholamban (PLB) were characterized. At CL 2000 ms, developed force was similar in the two groups. Decreasing CL increased developed force in the infant group to 131 +/- 8% (CL 1000 ms) and 157 +/- 18% (CL 500 ms) demonstrating a positive FFR. The FFR in the newborn group was flat. NCX mRNA and protein levels were significantly larger in the newborn than infant group whereas SERCA levels were unchanged. PLB mRNA levels and PLB/SERCA ratio increased with age. Immunostaining for NCX in isolated newborn cells showed peripheral staining. In infant cells, NCX was also found in T-tubules. SERCA staining was regular and striated in both groups. This study shows for the first time that the newborn human ventricle has a flat FFR, which increases with age and may be caused by developmental changes in calcium handling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19127223      PMCID: PMC2788428          DOI: 10.1203/PDR.0b013e318199093c

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  35 in total

1.  Both beta(2)- and beta(1)-adrenergic receptors mediate hastened relaxation and phosphorylation of phospholamban and troponin I in ventricular myocardium of Fallot infants, consistent with selective coupling of beta(2)-adrenergic receptors to G(s)-protein.

Authors:  P Molenaar; S Bartel; A Cochrane; D Vetter; H Jalali; P Pohlner; K Burrell; P Karczewski; E G Krause; A Kaumann
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

Review 2.  Modulation of thin filament activation by breakdown or isoform switching of thin filament proteins: physiological and pathological implications.

Authors:  Steven B Marston; Charles S Redwood
Journal:  Circ Res       Date:  2003-12-12       Impact factor: 17.367

3.  Gene expression of SERCA2a and L- and T-type Ca channels during human heart development.

Authors:  Y Qu; M Boutjdir
Journal:  Pediatr Res       Date:  2001-11       Impact factor: 3.756

4.  Allosteric regulation of Na/Ca exchange current by cytosolic Ca in intact cardiac myocytes.

Authors:  C R Weber; K S Ginsburg; K D Philipson; T R Shannon; D M Bers
Journal:  J Gen Physiol       Date:  2001-02       Impact factor: 4.086

5.  Sarcoplasmic reticulum Ca(2+)ATPase and cell contraction in developing rabbit heart.

Authors:  F Chen; S Ding; B S Lee; G T Wetzel
Journal:  J Mol Cell Cardiol       Date:  2000-05       Impact factor: 5.000

6.  Rate-dependent changes of twitch force duration in rat cardiac trabeculae: a property of the contractile system.

Authors:  Z Kassiri; R Myers; R Kaprielian; H S Banijamali; P H Backx
Journal:  J Physiol       Date:  2000-04-01       Impact factor: 5.182

7.  Effects of different inotropic interventions on myocardial function in the developing rabbit heart.

Authors:  Holger Schiffmann; Markus Flesch; Claudia Häuseler; Annette Pfahlberg; Michael Böhm; Gerhard Hellige
Journal:  Basic Res Cardiol       Date:  2002-01       Impact factor: 17.165

8.  Ontogeny of Ca2+-induced Ca2+ release in rabbit ventricular myocytes.

Authors:  Jingbo Huang; Leif Hove-Madsen; Glen F Tibbits
Journal:  Am J Physiol Cell Physiol       Date:  2007-12-19       Impact factor: 4.249

9.  Developmental differences in L-type calcium current of human atrial myocytes.

Authors:  Srinivas M Tipparaju; Rajiv Kumar; Yanggan Wang; Ronald W Joyner; Mary B Wagner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-01-08       Impact factor: 4.733

10.  Reduced sarcoplasmic reticulum Ca(2+) load mediates impaired contractile reserve in right ventricular pressure overload.

Authors:  Michael P Quaile; Eric I Rossman; Remus M Berretta; George Bratinov; Hajime Kubo; Steven R Houser; Kenneth B Margulies
Journal:  J Mol Cell Cardiol       Date:  2007-09-06       Impact factor: 5.000

View more
  39 in total

Review 1.  Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.

Authors:  Nicole T Feric; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2015-05-05       Impact factor: 15.470

2.  Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium.

Authors:  Irene C Turnbull; Ioannis Karakikes; Gregory W Serrao; Peter Backeris; Jia-Jye Lee; Chaoqin Xie; Grant Senyei; Ronald E Gordon; Ronald A Li; Fadi G Akar; Roger J Hajjar; Jean-Sébastien Hulot; Kevin D Costa
Journal:  FASEB J       Date:  2013-10-30       Impact factor: 5.191

Review 3.  Myocardial Tissue Engineering for Regenerative Applications.

Authors:  Buntaro Fujita; Wolfram-Hubertus Zimmermann
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

Review 4.  Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine.

Authors:  Elaheh Karbassi; Aidan Fenix; Silvia Marchiano; Naoto Muraoka; Kenta Nakamura; Xiulan Yang; Charles E Murry
Journal:  Nat Rev Cardiol       Date:  2020-02-03       Impact factor: 32.419

5.  One Stride Forward: Maturation and Scalable Production of Engineered Human Myocardium.

Authors:  Xiulan Yang; Charles E Murry
Journal:  Circulation       Date:  2017-05-09       Impact factor: 29.690

Review 6.  Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.

Authors:  Nazish Sayed; Chun Liu; Joseph C Wu
Journal:  J Am Coll Cardiol       Date:  2016-05-10       Impact factor: 24.094

7.  Outcomes and risk factors for mortality in premature neonates with critical congenital heart disease.

Authors:  Henry H Cheng; Melvin C Almodovar; Peter C Laussen; David Wypij; Angelo Polito; David W Brown; Sitaram M Emani; Frank A Pigula; Catherine K Allan; John M Costello
Journal:  Pediatr Cardiol       Date:  2011-06-29       Impact factor: 1.655

Review 8.  Towards chamber specific heart-on-a-chip for drug testing applications.

Authors:  Yimu Zhao; Naimeh Rafatian; Erika Yan Wang; Qinghua Wu; Benjamin F L Lai; Rick Xingze Lu; Houman Savoji; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2020-01-07       Impact factor: 15.470

9.  Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.

Authors:  Malte Tiburcy; James E Hudson; Paul Balfanz; Susanne Schlick; Tim Meyer; Mei-Ling Chang Liao; Elif Levent; Farah Raad; Sebastian Zeidler; Edgar Wingender; Johannes Riegler; Mouer Wang; Joseph D Gold; Izhak Kehat; Erich Wettwer; Ursula Ravens; Pieterjan Dierickx; Linda W van Laake; Marie Jose Goumans; Sara Khadjeh; Karl Toischer; Gerd Hasenfuss; Larry A Couture; Andreas Unger; Wolfgang A Linke; Toshiyuki Araki; Benjamin Neel; Gordon Keller; Lior Gepstein; Joseph C Wu; Wolfram-Hubertus Zimmermann
Journal:  Circulation       Date:  2017-02-06       Impact factor: 29.690

10.  Junctophilin-2 is necessary for T-tubule maturation during mouse heart development.

Authors:  Julia O Reynolds; David Y Chiang; Wei Wang; David L Beavers; Sayali S Dixit; Darlene G Skapura; Andrew P Landstrom; Long-Sheng Song; Michael J Ackerman; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2013-05-27       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.